Neuroprotective effect of alpha-kinase 1 knockdown against cerebral ischemia through inhibition of the NF-κB pathway and neuroinflammation
- 20 October 2022
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 113 (Pt A) , 109330
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- ALPK1 missense pathogenic variant in five families leads to ROSAH syndrome, an ocular multisystem autosomal dominant disorderGenetics in Medicine, 2019
- The CRISPR/Cas9 system and its applications in crop genome editingCritical Reviews in Biotechnology, 2019
- Alpha-kinase 1 is a cytosolic innate immune receptor for bacterial ADP-heptoseNature, 2018
- Ischemia/Reperfusion Induces Interferon-Stimulated Gene Expression in MicrogliaJournal of Neuroscience, 2017
- CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genesNature Biotechnology, 2016
- Association of genetic variants with coronary artery disease and ischemic stroke in a longitudinal population-based genetic epidemiological studyBiomedical Reports, 2015
- Neuroprotective effect of bicyclol in rat ischemic stroke: Down-regulates TLR4, TLR9, TRAF6, NF-κB, MMP-9 and up-regulates claudin-5 expressionBrain Research, 2013
- ALPK1 genetic regulation and risk in relation to goutInternational Journal of Epidemiology, 2013
- Identification of chromosome 3q28 and ALPK1 as susceptibility loci for chronic kidney disease in Japanese individuals by a genome-wide association studyJournal of Medical Genetics, 2013
- Alpha-kinases: a new class of protein kinases with a novel catalytic domainCurrent Biology, 1999